Mentat
Mentat is a mental fitness formula that supports brain function in both normal and demanding situations.
| Product dosage: 60caps | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 2 | $28.00 | $56.00 (0%) | 🛒 Add to cart |
| 3 | $26.33 | $84.00 $79.00 (6%) | 🛒 Add to cart |
| 4 | $25.25 | $112.00 $101.00 (10%) | 🛒 Add to cart |
| 5 | $24.60 | $140.00 $123.00 (12%) | 🛒 Add to cart |
| 6 | $24.33 | $168.00 $146.00 (13%) | 🛒 Add to cart |
| 7 | $24.00 | $196.00 $168.00 (14%) | 🛒 Add to cart |
| 8 | $23.88 | $224.00 $191.00 (15%) | 🛒 Add to cart |
| 9 | $23.67 | $252.00 $213.00 (15%) | 🛒 Add to cart |
| 10 | $23.60
Best per bottle | $280.00 $236.00 (16%) | 🛒 Add to cart |
Similar products
More info:
Aristocort: Advanced Topical Corticosteroid for Effective Inflammation Control
Aristocort (triamcinolone acetonide) is a mid-potency corticosteroid formulation designed for targeted anti-inflammatory and immunosuppressive action. As a trusted dermatological and systemic therapeutic agent, it offers physicians a versatile tool for managing a spectrum of inflammatory, allergic, and autoimmune conditions. Its well-established efficacy profile and multiple delivery forms—including creams, ointments, lotions, and injectable suspensions—make it a cornerstone in clinical practice for both acute flare management and chronic condition control. Features Contains triamcinolone acetonide, a synthetic glucocorticoid Available in multiple formulations: cream (0.
Cerecetam: Advanced Nootropic Support for Cognitive Enhancement
Cerecetam is a high-purity racetam-class nootropic agent designed to support cognitive function through targeted neurochemical modulation. As a derivative of the original piracetam molecule, it demonstrates enhanced bioavailability and receptor affinity, making it a subject of significant interest in neuropharmacology and cognitive enhancement circles. This compound is utilized by researchers, biohackers, and individuals seeking evidence-based cognitive support, particularly for memory formation, mental clarity, and neuroprotective benefits. Proper usage requires understanding its pharmacokinetics, safety profile, and potential synergies within a nootropic regimen.
Florinef: Effective Mineralocorticoid Therapy for Adrenal Insufficiency
Florinef (fludrocortisone acetate) is a synthetic corticosteroid with potent mineralocorticoid activity, primarily prescribed for the management of conditions involving aldosterone deficiency. It is a cornerstone therapy for adrenal insufficiency, including Addison’s disease, and is critical in maintaining electrolyte balance and blood pressure regulation. By mimicking the action of aldosterone, it promotes sodium reabsorption and potassium excretion in the kidneys, addressing the life-threatening imbalances caused by inadequate adrenal function. Its precise mechanism and well-established efficacy make it a first-line treatment in endocrinology for patients requiring long-term hormonal replacement.
Hydroxychloroquine: Immune Modulation for Chronic Conditions
Hydroxychloroquine is an oral disease-modifying antirheumatic drug (DMARD) with immunomodulatory properties, widely prescribed for autoimmune disorders and malaria prophylaxis. This antimalarial quinoline derivative demonstrates significant efficacy in managing inflammatory pathways through complex mechanisms involving Toll-like receptor signaling and cytokine modulation. Clinical applications extend beyond its original antimalarial indications to chronic autoimmune conditions requiring long-term immunoregulation. Features Chemical classification: 4-Aminoquinoline compound Available formulations: 200mg and 400mg oral tablets Mechanism: Lysosomal pH alteration and autophagy inhibition Bioavailability: Approximately 74% following oral administration Half-life: 40-50 days in plasma Metabolism: Hepatic via cytochrome P450 enzymes Excretion: Primarily renal (60%) with partial biliary elimination Benefits Provides sustained suppression of autoimmune activity through immunomodulatory mechanisms Reduces disease progression and joint damage in inflammatory arthritides Demonstrates steroid-sparing effects in systemic lupus erythematosus management Offers convenient once-daily dosing regimen for improved adherence Shows favorable long-term safety profile compared to biologic DMARDs Provides cost-effective disease modification in resource-limited settings Common use Hydroxychloroquine is primarily indicated for the treatment of uncomplicated malaria caused by Plasmodium vivax, P.
Prednisolone: Potent Anti-Inflammatory Relief for Immune-Mediated Conditions
Prednisolone is a potent synthetic glucocorticoid medication widely utilized in clinical practice for its robust anti-inflammatory and immunosuppressive properties. As a cornerstone therapy in managing numerous acute and chronic conditions, it modifies the body’s immune response and reduces inflammation at the cellular level. Its efficacy spans multiple medical specialties, from rheumatology and pulmonology to dermatology and hematology, making it an indispensable tool for physicians. Proper understanding of its pharmacokinetics, indications, and safety profile is essential for optimizing therapeutic outcomes while minimizing risks.
Advanced Diclofenac Emulgel for Targeted Pain Relief
Diclofenac Emulgel represents a significant advancement in topical analgesic therapy, combining the proven efficacy of diclofenac with innovative emulsion gel technology. This pharmaceutical formulation is specifically engineered to provide targeted relief from musculoskeletal pain and inflammation while minimizing systemic exposure. Developed through extensive clinical research, this emulgel offers healthcare professionals and patients a sophisticated alternative to oral NSAIDs, particularly for localized conditions where direct application is advantageous. Its unique carrier system ensures optimal drug penetration and bioavailability at the site of application.
Arava: Targeted Symptom Control for Rheumatoid Arthritis
Arava (leflunomide) is a disease-modifying antirheumatic drug (DMARD) specifically engineered to manage the symptoms and progression of rheumatoid arthritis. By selectively inhibiting pyrimidine synthesis in activated lymphocytes, it reduces inflammation, minimizes joint damage, and helps preserve physical function. This oral treatment offers a convenient therapeutic option for adults with moderate to severe active rheumatoid arthritis, providing sustained relief and improving quality of life. Clinical studies demonstrate its efficacy in reducing tender and swollen joint counts and slowing radiographic progression.
Arcoxia: Targeted Relief for Chronic Osteoarthritis and Pain
Arcoxia (etoricoxib) is a prescription medication belonging to the class of drugs known as selective COX-2 inhibitors, a type of nonsteroidal anti-inflammatory drug (NSAID). It is specifically engineered to provide potent anti-inflammatory and analgesic effects by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which is responsible for pain and inflammation, while largely sparing the COX-1 enzyme involved in protecting the stomach lining. This mechanism offers a refined approach to managing chronic musculoskeletal conditions, particularly osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute gouty arthritis and primary dysmenorrhea.
Asacol: Targeted Relief for Ulcerative Colitis Symptoms
Asacol (mesalamine) is a prescription medication specifically formulated for the treatment of mild to moderate ulcerative colitis. It belongs to the class of aminosalicylates and works locally in the colon to reduce inflammation, helping to induce and maintain remission. This delayed-release formulation ensures the active ingredient is delivered directly to the site of disease activity, minimizing systemic absorption and optimizing therapeutic efficacy for appropriate patients under medical supervision. Features Active ingredient: Mesalamine (5-aminosalicylic acid or 5-ASA) Formulation: Delayed-release tablets designed for targeted colonic release Available strengths: 400 mg and 800 mg delayed-release tablets pH-dependent coating that dissolves at pH ≥7, typically in the terminal ileum and colon Designed to minimize systemic absorption while maximizing local anti-inflammatory effects Benefits Effectively reduces inflammation in the colon to control ulcerative colitis symptoms Helps achieve and maintain clinical remission in mild to moderate cases Targeted delivery system minimizes systemic exposure and potential side effects Demonstrated efficacy in reducing relapse rates when used as maintenance therapy Generally well-tolerated with a favorable safety profile compared to systemic therapies Convenient oral administration that supports long-term treatment adherence Common use Asacol is indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older.